Comment
doi: 10.1016/S1470-2045(13)70610-7.
Epub 2014 Jan 16.
Adjuvant chemotherapy for local relapse breast cancer
Affiliations
- PMID: 24439312
- DOI: 10.1016/S1470-2045(13)70610-7
Item in Clipboard
Comment
Adjuvant chemotherapy for local relapse breast cancer
Lancet Oncol.
2014 Feb.
No abstract available
Comment on
-
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.Lancet Oncol. 2014 Feb;15(2):156-63. doi: 10.1016/S1470-2045(13)70589-8. Epub 2014 Jan 16. Lancet Oncol. 2014. PMID: 24439313 Free PMC article. Clinical Trial.
Similar articles
-
Adjuvant treatment in high-risk breast cancer.Br J Hosp Med. 1996 Feb 21-Mar 5;55(4):156-8. Br J Hosp Med. 1996. PMID: 8777488 Clinical Trial. No abstract available.
-
Breast cancer: CALOR favours adjuvant therapy for ILRR of breast cancer.Nat Rev Clin Oncol. 2014 Mar;11(3):120. doi: 10.1038/nrclinonc.2014.13. Epub 2014 Feb 4. Nat Rev Clin Oncol. 2014. PMID: 24492831 No abstract available.
-
Increasing Precision in Adjuvant Therapy for Breast Cancer.N Engl J Med. 2016 Aug 25;375(8):790-1. doi: 10.1056/NEJMe1607947. N Engl J Med. 2016. PMID: 27557306 No abstract available.
-
The role of systemic therapy in early breast cancer.N C Med J. 1987 Oct;48(10):535-8. N C Med J. 1987. PMID: 3317072 Review. No abstract available.
-
[Preoperative chemotherapy in breast cancer].Chirurg. 1992 Jun;63(6):469-76. Chirurg. 1992. PMID: 1643983 Review. German. No abstract available.
Cited by
-
Hsa-miR-599 suppresses the migration and invasion by targeting BRD4 in breast cancer.Oncol Lett. 2017 Sep;14(3):3455-3462. doi: 10.3892/ol.2017.6651. Epub 2017 Jul 21. Oncol Lett. 2017. PMID: 28927100 Free PMC article.
-
miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition.Am J Transl Res. 2016 Jul 15;8(7):3106-14. eCollection 2016. Am J Transl Res. 2016. PMID: 27508031 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
